CenterBook Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $373K | Buy |
+921
| New | +$373K | 0.02% | 473 |
|
2025
Q1 | – | Sell |
-1,327
| Closed | -$690K | – | 600 |
|
2024
Q4 | $690K | Buy |
1,327
+972
| +274% | +$506K | 0.04% | 383 |
|
2024
Q3 | $220K | Sell |
355
-2,486
| -88% | -$1.54M | 0.01% | 435 |
|
2024
Q2 | $1.57M | Sell |
2,841
-2,233
| -44% | -$1.23M | 0.1% | 289 |
|
2024
Q1 | $2.95M | Buy |
5,074
+1,378
| +37% | +$801K | 0.2% | 184 |
|
2023
Q4 | $1.96M | Buy |
3,696
+176
| +5% | +$93.4K | 0.24% | 149 |
|
2023
Q3 | $1.78M | Sell |
3,520
-1,276
| -27% | -$646K | 0.22% | 153 |
|
2023
Q2 | $2.5M | Buy |
4,796
+2,334
| +95% | +$1.22M | 0.31% | 110 |
|
2023
Q1 | $1.42M | Sell |
2,462
-312
| -11% | -$180K | 0.2% | 163 |
|
2022
Q4 | $1.53M | Buy |
2,774
+1,370
| +98% | +$754K | 0.25% | 141 |
|
2022
Q3 | $712K | Buy |
+1,404
| New | +$712K | 0.14% | 241 |
|